U.S. markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.26+0.29 (+1.71%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts11111111
Avg. Estimate-0.24-0.27-1.11-0.73
Low Estimate-0.34-0.35-1.35-1.17
High Estimate-0.15-0.19-0.88-0.25
Year Ago EPS-0.24-0.26-1.09-1.11
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts991010
Avg. Estimate28.48M23.96M100.47M174.18M
Low Estimate14.34M15.32M66.31M130M
High Estimate44M37M141M246M
Year Ago Sales2.87M3.6M17.81M100.47M
Sales Growth (year/est)892.00%565.60%464.10%73.40%
Earnings History6/29/20209/29/202012/30/20203/30/2021
EPS Est.-0.25-0.25-0.25-0.27
EPS Actual-0.24-0.26-0.34-0.36
Difference0.01-0.01-0.09-0.09
Surprise %4.00%-4.00%-36.00%-33.30%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.24-0.27-1.11-0.73
7 Days Ago-0.24-0.27-1.11-0.73
30 Days Ago-0.24-0.27-1.11-0.73
60 Days Ago-0.25-0.27-1.08-0.74
90 Days Ago-0.25-0.26-1.03-0.73
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/A1
Up Last 30 DaysN/AN/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesBCRXIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.-3.80%N/AN/AN/A
Current Year-1.80%N/AN/AN/A
Next Year34.20%N/AN/AN/A
Next 5 Years (per annum)19.90%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A